Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

U.S. extends public health emergency status for COVID

Published 01/11/2023, 10:42 AM
Updated 01/11/2023, 12:11 PM
© Reuters. FILE PHOTO: People wear masks as a protection against the coronavirus disease (COVID-19) pandemic in New York City, New York, U.S., December 12, 2022. REUTERS/Eduardo Munoz

By Ahmed Aboulenein

(Reuters) -The U.S. health department on Wednesday extended the COVID-19 pandemic's status as a public health emergency, allowing millions of Americans to continue receiving free tests, vaccines and treatments.

The emergency was first declared in January 2020, when the coronavirus pandemic began, and has been renewed each quarter since then. It was due to end this week.

The increased availability of vaccines and medications has significantly diminished the COVID-19 pandemic's toll since early in President Joe Biden's term, when more than 3,000 Americans per day were dying.

But hundreds of people a day continue to die from the coronavirus in the United States, according to the U.S. Centers for Disease Control and Prevention (CDC).

Daily U.S. cases, while well below last January's record Omicron surge levels, have climbed up to an average of over 67,000 as of Jan. 4, with some 390 COVID-related deaths a day, according to the latest CDC data.

Biden administration officials had said in November that the possibility of a winter surge in COVID cases and the need for more time to transition to a private market for the sale of tests, vaccines and treatments were two factors that contributed to the decision not to end the emergency status in January.

When it expires, private insurance and government health plans will take on COVID healthcare costs for most Americans.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.